keyword
https://read.qxmd.com/read/38651365/multicomponent-synergistic-antibacterial-hydrogel-based-on-gelatin-oxidized-carboxymethyl-cellulose-for-wound-healing-of-drug-resistant-chronic-infection
#21
JOURNAL ARTICLE
Jiaxu Zhang, Liangyu Wang, Xiaoyue Wang, Yusen Xu, Dongzhi Yang, Jun Nie, Guiping Ma
Bacterial invasion hinders the healing process of wound, leading to the formation of chronic infected wound; meanwhile, the misuse of antibiotics has resulted in the emergence of numerous drug-resistant bacteria. The application of conventional antimicrobial methods and wound treatment techniques is not appropriate for wound dressings. In this paper, quaternized poly(vinyl alcohol) (QPVA) and pomegranate-like copper uniformly doped polydopamine nanoparticles (PDA@Cu) were introduced into a gelatin-oxidized carboxymethyl cellulose system to form a multicomponent synergistic antibacterial hydrogel (GOQ3 P3 )...
April 23, 2024: ACS Applied Bio Materials
https://read.qxmd.com/read/38651271/development-of-an-efficient-liposomal-dox-delivery-formulation-for-hcc-therapy-by-targeting-ck2%C3%AE
#22
JOURNAL ARTICLE
Ruixia Zhao, Sinan Cheng, Xue Bai, Danying Zhang, Hongming Fang, Wanlin Che, Wenxuan Zhang, Yujuan Zhou, Wei Duan, Qiumin Liang, Li Xiao, Guochao Nie, Yingchun Hou
Hepatocellular carcinoma (HCC) is a digestive tract cancer with high mortality and poor prognosis, especially in China. Current chemotherapeutic drugs lead to poor prognosis, low efficacy, and high side effects due to weak targeting specificity and rapidly formed multidrug resistance (MDR). Based on the previous studies on the doxorubicin (DOX) formulation for cancer targeting therapy, we developed a novel DOX delivery formulation for the targeting chemotherapy of HCC and DOX resistant HCC. HCSP4 was previously screened and casein kinase 2α (CK2α) was predicted as its specific target on HCC cells in our lab...
April 2024: Biotechnology Journal
https://read.qxmd.com/read/38651235/custom-design-of-multi-stimuli-responsive-degradable-silica-nanoparticles-for-advanced-cancer-specific-chemotherapy
#23
REVIEW
Junjie Zhang, Jiani Zhou, Longguang Tang, Jiayi Ma, Ying Wang, Hui Yang, Xiaoxiao Wang, Wenpei Fan
Chemotherapy is crucial in oncology for combating malignant tumors but often encounters obatacles such as severe adverse effects, drug resistance, and biocompatibility issues. The advantages of degradable silica nanoparticles in tumor diagnosis and treatment lie in their ability to target drug delivery, minimizing toxicity to normal tissues while enhancing therapeutic efficacy. Moreover, their responsiveness to both endogenous and exogenous stimuli opens up new possibilities for integrating multiple treatment modalities...
April 23, 2024: Small
https://read.qxmd.com/read/38651177/effectiveness-and-infectious-complications-of-bcma-t-cell-engagers-in-treating-multiple-myeloma-real-world-evidence-from-sweden
#24
JOURNAL ARTICLE
Katarina Uttervall, Love Tätting, Konstantinos Lemonakis, Mousa Majd, Jacob Crafoord, Mikael Olsson, Ulf-Henrik Mellqvist, Markus Hansson, Hareth Nahi
BACKGROUND: Multiple myeloma (MM), an incurable disease characterized by frequent relapses and a need for multiple treatments, often progresses to a relapse/refractory status resistant to all available drugs and drug classes. Bispecific antibodies, specifically BCMA T-cell engagers, have emerged as effective treatments for MM, demonstrating impressive efficacy. However, these treatments can adversely affect the immune system, increasing vulnerability to infections. METHODS/RESULTS: This study evaluated the efficacy and safety of BCMA T-cell engagers in 58 Swedish patients with poor MM prognosis...
April 2024: Cancer Medicine
https://read.qxmd.com/read/38651147/co-operation-of-mcl-1-and-bcl-x-l-anti-apoptotic-proteins-in-stromal-protection-of-mm-cells-from-carfilzomib-mediated-cytotoxicity
#25
JOURNAL ARTICLE
Daria Galas-Filipowicz, Selina J Chavda, Jia-Nan Gong, David C S Huang, Asim Khwaja, Kwee Yong
INTRODUCTION: BCL-2 family proteins are important for tumour cell survival and drug resistance in multiple myeloma (MM). Although proteasome inhibitors are effective anti-myeloma drugs, some patients are resistant and almost all eventually relapse. We examined the function of BCL-2 family proteins in stromal-mediated resistance to carfilzomib-induced cytotoxicity in MM cells. METHODS: Co-cultures employing HS5 stromal cells were used to model the interaction with stroma...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38651137/hepatitis-c-virus-antiviral-drug-resistance-and-salvage-therapy-outcomes-across-australia
#26
JOURNAL ARTICLE
Dao Sen Wang, Amy Phu, Kristen McKee, Simone I Strasser, Sinead Sheils, Martin Weltman, Sue Sellar, Joshua S Davis, Mel Young, Alicia Braund, Geoffrey C Farrell, Anne Blunn, Damian Harding, Lucy Ralton, Kate Muller, Scott A Davison, David Shaw, Marnie Wood, Krispin Hajkowicz, Richard Skolen, Jane Davies, Jaclyn Tate-Baker, Adam Doyle, Rhoda Tuma, Simon Hazeldine, Wendy Lam, Natalie Edmiston, Krista Zohrab, William Pratt, Belinda Watson, Amany Zekry, Carlie Stephens, Paul J Clark, Melany Day, Gordon Park, Hami Kim, Mark Wilson, Bruce McGarity, Natalie Menzies, Darren Russell, Thao Lam, Peter Boyd, Jen Kok, Jacob George, Mark W Douglas
BACKGROUND: Hepatitis C virus (HCV) infection can now be cured with well-tolerated direct-acting antiviral (DAA) therapy. However, a potential barrier to HCV elimination is the emergence of resistance-associated substitutions (RASs) that reduce the efficacy of antiviral drugs, but real-world studies assessing the clinical impact of RASs are limited. Here, an analysis of the impact of RASs on retreatment outcomes for different salvage regimens in patients nationally who failed first-line DAA therapy is reported...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38650929/ferroptosis-in-liver-cancer-a-key-role-of-post-translational-modifications
#27
REVIEW
Ying Xu, Zhiyao Xing, Ruaa Abdalla Ibrahim Suliman, Zichuan Liu, Fengyuan Tang
Ferroptosis is an emerging form of regulated cell death in an oxidative stress- and iron-dependent manner, primarily induced by the over-production of reactive oxygen species (ROS). Manipulation of ferroptosis has been considered a promising therapeutic approach to inhibit liver tumor growth. Nevertheless, the development of resistance to ferroptosis in liver cancer poses a significant challenge in cancer treatment. Post-translational modifications (PTMs) are crucial enzymatic catalytic reactions that covalently regulate protein conformation, stability and cellular activities...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38650911/isotretinoin-self-nano-emulsifying-drug-delivery-system-preparation-optimization-and-antibacterial-evaluation
#28
JOURNAL ARTICLE
Rihaf Alfaraj, Sandra Hababah, Esra K Eltayb, Fulwah Y Alqahtani, Fadilah S Aleanizy
PURPOSE: Isotretinoin (ITN) is a poorly water-soluble drug. The objective of this study was to design a successful liquid self-nanoemulsifying drug delivery system (L-SNEDDS) for ITN to improve its solubility, dissolution rate, and antibacterial activity. METHODS: According to solubility and emulsification studies, castor oil, Cremophor EL, and Transcutol HP were selected as system excipients. A pseudo ternary phase diagram was constructed to reveal the self-emulsification area...
June 2024: Saudi Pharmaceutical Journal: SPJ: the Official Publication of the Saudi Pharmaceutical Society
https://read.qxmd.com/read/38650875/antibacterial-efficacy-of-novel-bismuth-silver-nanoparticles-synthesis-on-staphylococcus-aureus-and-escherichia-coli-infection-models
#29
JOURNAL ARTICLE
Beatriz Elena Castro-Valenzuela, Moisés Armides Franco-Molina, Diana Ginette Zárate-Triviño, Licet Villarreal-Treviño, Jorge R Kawas, Paola Leonor García-Coronado, Gustavo Sobrevilla-Hernández, Cristina Rodríguez-Padilla
INTRODUCTION: The emergence of multi-drug-resistant bacteria is one of the main concerns in the health sector worldwide. The conventional strategies for treatment and prophylaxis against microbial infections include the use of antibiotics. However, these drugs are failing due to the increasing antimicrobial resistance. The unavailability of effective antibiotics highlights the need to discover effective alternatives to combat bacterial infections. One option is the use of metallic nanoparticles, which are toxic to some microorganisms due to their nanometric size...
2024: Frontiers in Microbiology
https://read.qxmd.com/read/38650815/green-synthesis-of-molybdenum-nanoparticles-from-solanum-xanthocarpum-and-evaluation-of-their-antimicrobial-and-antioxidant-activity-against-multidrug-resistant-wound-isolates
#30
JOURNAL ARTICLE
Priyam Bharathidasan, Muthuvel Surya, P Geetha Sravanthy, Muthupandian Saravanan
INTRODUCTION: In recent years, antimicrobial drug resistance has emerged as a serious global public health concern, according to the World Health Organization data. The emergence of pathogens resistant to multiple drugs has been linked to an increase in morbidity and mortality from microbial infections. The study's main goal is to explore the efficacy of using Solanum xanthocarpum in the green synthesis of molybdenum nanoparticles (Mo NPs) for antibacterial and antioxidant properties...
March 2024: Curēus
https://read.qxmd.com/read/38650755/clinical-characteristics-and-analysis-of-associated-risk-factors-in-patients-with-severe-and-non-severe-covid-19-infection
#31
JOURNAL ARTICLE
Yong Zhou, Zhen Wang, Fei Chen, Ying-Xia Xiong, Wei Wang, Jun-Min Huang, Wei Fang
OBJECTIVE: Our aim was to highlight the clinical characteristics and determine the risk factors associated with severe and non-severe COVID-19 infection. STUDY METHOD: A retrospective review was conducted on clinical data obtained from patients with COVID-19 infection, admitted to the emergency department between November 2022 and January 2023. Total of 1684 participants were categorized into severe (312 cases,18.53%) and non-severe (1,372 cases,81.47%) cohorts...
2024: Infection and Drug Resistance
https://read.qxmd.com/read/38650754/pd-1-blockade-induced-hemophagocytic-lymphohistiocytosis-a-dilemma-therapeutic-outcome-in-2-patients-with-caebv-a-case-series
#32
LeiLei Chen, Jingshi Wang, Zhao Wang
Hemophagocytic lymphohistiocytosis (HLH), whether primary or secondary, is a rare and fatal clinical syndrome of uncontrolled immune activation and inflammatory cascade. Immune checkpoint inhibitors (ICIs) induced HLH has no standard diagnostic and treatment guidelines. Early diagnosis and appropriate treatment according to different disease backgrounds are crucial. Herein, we first report 2 cases of patients with chronic active Epstein-Barr virus infection (CAEBV) who developed HLH after the use of sintilimab, a monoclonal antibody against programmed cell death protein 1 (PD-1), and the DEP (liposomal doxorubicin, etoposide, methylprednisolone) chemotherapy regimen in combination with ruxolitinib were used to successfully control the disease...
2024: Infection and Drug Resistance
https://read.qxmd.com/read/38650753/predicting-antibiotic-tolerance-in-hvkp-and-ckp-respiratory-infections-through-biofilm-formation-analysis-and-its-resistance-implications
#33
JOURNAL ARTICLE
Zhongwei Wen, Yiqiang Chen, Tangjuan Liu, Jiahui Han, Yuting Jiang, Ke Zhang
INTRODUCTION: Respiratory infections are a major global health concern, with Klebsiella pneumoniae standing out due to its evolving antibiotic resistance. This study compares the resistance profiles of hypervirulent Klebsiella pneumoniae (hvKP) and classical Klebsiella pneumoniae (cKP), aiming to shed light on their clinical implications. METHODS: We analyzed 86 cases, comprising 42 hvKP and 44 cKP strains, using comprehensive antimicrobial susceptibility testing and clinical data evaluation to assess antibiotic tolerance and resistance mechanisms...
2024: Infection and Drug Resistance
https://read.qxmd.com/read/38650742/bioactive-compounds-from-morchella-esculenta-as-potential-inhibitors-of-rna-binding-protein-la-in-ovarian-cancer-a-molecular-modeling-and-quantum-mechanics-approach
#34
JOURNAL ARTICLE
Gbenga Dairo, Matthew N Ward, Mette Soendergaard, John J Determan
La protein is significantly expressed in various malignant tumors, including ovarian cancer (OC), which is related to the poor response to platinum-based chemotherapy. Thus, inhibiting La protein could control the expression of the potential downstream genes involved in promoting proliferation and chemotherapy resistance to OC, which could serve as a therapeutic intervention. Through a molecular docking approach, 12 compounds from Morchella esculenta were screened against the crystal structure of La protein and four hit compounds were identified, including beta-carotene, p -hydroxybenzoic acid, gamma-tocopherol, and alpha-tocopherol, with a binding affinity of - 10...
2024: In Silico Pharmacology
https://read.qxmd.com/read/38650393/evaluation-of-omadacycline-regimens-for-community-acquired-bacterial-pneumonia-patients-infected-with-staphylococcus-aureus-by-pharmacokinetic-pharmacodynamic-analysis
#35
JOURNAL ARTICLE
Gaoqi Xu, Xin Liu, Jiaqi Wang, Yuqing Mei, Dihong Yang, Chaoneng He, Like Zhong, Junfeng Zhu, Haiying Ding, Luo Fang
Omadacycline is an FDA-approved agent for community-acquired bacterial pneumonia (CABP). The purpose of this study is to evaluate the effectiveness of omadacycline for treating CABP patients infected with Staphylococcus aureus , including Methicillin-Resistant Staphylococcus aureus (MRSA) and Methicillin-Susceptible Staphylococcus aureus (MSSA), using pharmacokinetic/pharmacodynamic (PK/PD) analysis. Monte Carlo simulations (MCSs) were performed by utilizing omadacycline pharmacokinetic (PK) parameters, minimum inhibitory concentration (MIC) data, and in vivo PK/PD targets to calculate the probability of target attainment (PTA) and cumulative fraction of response (CFR) values for different dose regimens against MRSA and MSSA in CABP patients...
April 22, 2024: Journal of Chemotherapy
https://read.qxmd.com/read/38650051/the-clinical-value-of-mngs-of-bronchoalveolar-lavage-fluid-versus-traditional-microbiological-tests-for-pathogen-identification-and-prognosis-of-severe-pneumonia-nt-balf-study-protocol-for-a-prospective-multi-center-randomized-clinical-trial
#36
JOURNAL ARTICLE
Xiao Song, Hui Jiang, Liang Zong, Di Shi, Huadong Zhu
BACKGROUND: Early, rapid, and accurate pathogen diagnosis can help clinicians select targeted treatment options, thus improving prognosis and reducing mortality rates of severe pneumonia. Metagenomic next-generation sequencing (mNGS) has a higher sensitivity and broader pathogen spectrum than traditional microbiological tests. However, the effects of mNGS-based antimicrobial treatment procedures on clinical outcomes and cost-effectiveness in patients with severe pneumonia have not been evaluated...
April 22, 2024: Trials
https://read.qxmd.com/read/38649973/genetic-exploration-of-dravet-syndrome-two-case-report
#37
JOURNAL ARTICLE
Agung Triono, Elisabeth Siti Herini, Gunadi
BACKGROUND: Dravet syndrome is an infantile-onset developmental and epileptic encephalopathy (DEE) characterized by drug resistance, intractable seizures, and developmental comorbidities. This article focuses on manifestations in two Indonesian children with Javanese ethnicity who experienced Dravet syndrome with an SCN1A gene mutation, presenting genetic analysis findings using next-generation sequencing. CASE PRESENTATION: We present a case series involving two Indonesian children with Javanese ethnicity whom had their first febrile seizure at the age of 3 months, triggered after immunization...
April 23, 2024: Journal of Medical Case Reports
https://read.qxmd.com/read/38649719/a-novel-multidrug-resistant-cell-line-from-a-chinese-patient-with-pancreatic-ductal-adenocarcinoma
#38
JOURNAL ARTICLE
Huan Tang, Xin Miao, Cheng Yu, Changpeng Chai, Yuanhui Su, Lu Li, Jianfeng Yi, Zhenzhen Ye, Long Miao, Zhengfeng Wang, Hui Zhang, Hao Xu, Wence Zhou
Chemotherapy resistance poses clinical challenges in pancreatic cancer treatment. Developing cell lines resistant to chemotherapy is crucial for investigating drug resistance mechanisms and identifying alternative treatment pathways. The genetic and biological attributes of pancreatic cancer depend on its aetiology, racial demographics and anatomical origin, underscoring the need for models that comprehensively represent these characteristics. Here, we introduce PDAC-X2, a pancreatic cancer cell line derived from Chinese patients...
April 22, 2024: Scientific Reports
https://read.qxmd.com/read/38649655/perspectives-for-the-clinical-application-of-ctdna-analysis-to-breast-cancer-drug-therapy
#39
JOURNAL ARTICLE
Tetsuhiro Yoshinami
Circulating tumor DNA (ctDNA) consists of DNA fragments released from cancer cells into the blood circulation with quick clearance. Analysis of ctDNA can enable real-time assessment of the presence of cancer cells and their genomic characteristics. Therefore, ctDNA is expected to be one of the most useful biomarkers for cancer. In recent years, several ultra-sensitive assays for ctDNA analysis have been developed, and many clinical trials are using these assays to investigate the efficacy of ctDNA-based therapeutic strategies...
April 23, 2024: Breast Cancer: the Journal of the Japanese Breast Cancer Society
https://read.qxmd.com/read/38649550/third-generation-solid-dispersion-based-formulation-of-novel-anti-tubercular-agent-exhibited-improvement%C3%A2-in-solubility-dissolution-and-biological-activity
#40
JOURNAL ARTICLE
Gourav Paudwal, Rigzin Dolkar, Summaya Perveen, Rashmi Sharma, Parvinder Pal Singh, Prem N Gupta
The long treatment period and development of drug resistance in tuberculosis (TB) necessitates the discovery of new anti-tubercular agents. The drug discovery program of the institute leads to the development of an anti-tubercular lead (IIIM-019), which is an analogue of nitrodihydroimidazooxazole and exhibited promising anti-tubercular action. However, IIIM-019 displays poor aqueous solubility (1.2 µg/mL), which demands suitable dosage form for its efficient oral administration. In the present study, third generation solid dispersion-based formulation was developed to increase the solubility and dissolution of IIIM-019...
April 22, 2024: AAPS Journal
keyword
keyword
60452
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.